miDiagnostics Funding: $180M Raised, Series D (2024)
miDiagnostics is based in Leuven, Belgium. It has raised $180M in total funding. Latest round: Series D.
miDiagnostics funding overview
miDiagnostics is based in Leuven, Belgium. miDiagnostics has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2024. The round record for miDiagnostics runs through 2024; nothing later has been disclosed. Investors on record include Thermo Fisher Scientific, Alychlo, VMF Invest, Pamica. 4 distinct backers are named across the disclosed rounds.
miDiagnostics has raised $180M in total disclosed funding across the rounds on record.
Who has invested in miDiagnostics?
Thermo Fisher Scientific, Alychlo, VMF Invest, Pamica are named among the investors backing miDiagnostics.
What was the latest miDiagnostics funding round?
The most recent disclosed round is a Series D, announced in December 2024.
Where is miDiagnostics based?
miDiagnostics is based in Leuven, Belgium.
When did miDiagnostics last raise?
The last disclosed miDiagnostics round closed in December 2024 at Series D.
Totals shown for miDiagnostics aggregate every disclosed round on file. To see how that compares, browse the companies in Leuven and the investors behind them below.
